Press release
Bacterial Vaginosis Market Insights, Epidemiology, and Market Forecast 2034 by Delveinsight
"The market size of Bacterial Vaginosis is expected to increase during the forecast period with the increasing prevalence, disease awareness, and promising emerging treatment options by leading companies such as Lupin, Osel, Dare Bioscience, Organon"[Nevada, United States] - DelveInsight, a leading market research company, is excited to introduce its newest report, titled "Bacterial Vaginosis Market Insights, Epidemiology, and Market Forecast 2034." This innovative report offers a detailed examination of Bacterial Vaginosis Market, covering historical and predicted epidemiology, market trends, and treatment scenarios in the United States, EU4 (Germany, Spain, Italy, France), the United Kingdom, and Japan.
To Know in detail about the Bacterial Vaginosis market outlook, drug uptake, treatment scenario and epidemiology trends, Click here: https://www.delveinsight.com/report-store/bacterial-vaginosis-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=rkpr
Key Findings from the Bacterial Vaginosis Market Report:
The Bacterial Vaginosis Market size is poised for significant growth, with an anticipated Compound Annual Growth Rate (CAGR) during the study period (2020-2034).
In August, 2024: Teva Pharmaceuticals announces that the purpose of their study was to demonstrate comparable efficacy, safety, and tolerability of Teva Pharmaceuticals USA's generic formulation of Metronidazole Vaginal Gel, 0.75% and 3M Pharmaceuticals' MetroGel-Vaginal® metronidazole vaginal gel, 0.75% to establish clinical equivalence in the treatment of bacterial vaginosis.
In July,2024 Scynexis, Inc. disclosed that their study will treat subjects with complicated VVC who have failed prior fluconazole therapy with Ibrexafungerp for 1, 3 or 7 days of treatment.
In May,2024: Avva Rus, JSC says that the purpose of their study is to study superior efficacy of combination of Natamycin and Lactulose (Natamycin 100 mg + Lactulose 300 mg vaginal suppositories) compared to Pimafucin (Natamycin 100 mg vaginal suppositories), or Lactulose 300 mg vaginal suppositories.
As per Centers for Disease Control and Prevention, Bacterial vaginosis is the most common cause of vaginal symptoms among women, but it is not clear what role sexual activity plays in the development of BV. The prevalence in the United States is estimated to be 21.2 million (29.2%) among women ages 14-49, based on a nationally representative sample of women who participated in NHANES 2001-2004.
According to Kairys et al., 2019, BV is the most common vaginal infection found in women of reproductive age and is estimated to occur in anywhere from 5-70% of women. As per the global epidemiology stats BV is most common in parts of Africa and is found to be least common in Asia and Europe. In the United States,about 30% of women ages between 14-49 are affected, however, rates are variable between different ethnic groups and are most common in non-white women
As per the American Sexual Health Association 2019, Bacterial Vaginosis is a common gynecologic infection, affecting nearly29% of women in the US
Key Bacterial Vaginosis Market Companies: Lupin, Osel, Dare Bioscience, Organon
Key Therapies have been identified such as: Metronidazole, LACTIN-V, Placebo, Ibrexafungerp, Secnidazole.
Launching multiple stage Bacterial Vaginosis Market pipeline products is expected to revolutionize market dynamics, further propelling market growth.
Get a Free sample for the Bacterial Vaginosis Market Report: https://www.delveinsight.com/sample-request/bacterial-vaginosis-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=rkpr
Bacterial Vaginosis Overview:
Bacterial vaginosis (BV) also referred to as nonspecific vaginitis, is a vaginal condition that can produce vaginal discharge and results from an overgrowth of certain kinds of bacteria in the vagina. Bacterial vaginosis is the most common infectious vaginitis. The exact cause of bacterial vaginosis is unknown. There are several bacteria associated with it.
Bacterial Vaginosis Market Drugs Uptake and Pipeline Development Activities:
The drugs uptake section examines how quickly newly launched or anticipated drugs are adopted during the study period. It details the market uptake for each drug, patient uptake for different therapies, and the sales figures for each drug. Furthermore, the report offers insights into the pipeline development activities within the Bacterial Vaginosis Market, including an analysis of therapeutic candidates at various stages and the key companies involved.
For more information about Bacterial Vaginosis Market companies working in the treatment market, visit: https://www.delveinsight.com/sample-request/bacterial-vaginosis-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=rkpr
Bacterial Vaginosis Epidemiology:
The epidemiology section offers an analysis of historical, present, and projected trends in the seven major countries (7MM) from 2020 to 2034. It examines various studies and perspectives to identify the factors driving these trends. The segmentation covers overall prevalence, prevalence based on severity, gender-specific prevalence, and the number of diagnosed cases of both episodic and chronic Bacterial Vaginosis.
Bacterial Vaginosis Epidemiology Segmentation:
The Bacterial Vaginosis Market report proffers epidemiological analysis for the study period 2020-2034 in the 7MM segmented into:
Bacterial Vaginosis Total Prevalence
Bacterial Vaginosis Prevalent Cases by severity
Bacterial Vaginosis Gender-specific Prevalence
Bacterial Vaginosis Diagnosed Cases of Episodic and Chronic
Bacterial Vaginosis Market Therapies and Key Companies:
XACIATO: Organon/Daré Bioscience
SOLOSEC: Lupin
LACTIN-V: Osel
Bacterial Vaginosis Market Drivers and Barriers:
The Bacterial Vaginosis Market Forecast report highlights key drivers and barriers shaping the Bacterial Vaginosis Market dynamics, providing insights into factors influencing growth and challenges that may be encountered.
Stay Ahead in a Competitive Landscape with Our Exhaustive Market Research Report-Dive Into Detailed Analysis, Key Trends, and Future Projections @ https://www.delveinsight.com/sample-request/bacterial-vaginosis-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=rkpr
Scope of the Bacterial Vaginosis Market Report:
Study Period: 2020-2034
Coverage: 7MM (The United States, EU5, and Japan)
Key Bacterial Vaginosis Companies: Lupin, Osel, Dare Bioscience, Organon
Key Bacterial Vaginosis Therapies: Metronidazole, LACTIN-V, Placebo, Ibrexafungerp, Secnidazole, XACIATO, SOLOSEC, LACTIN-V.
Bacterial Vaginosis Market Therapeutic Assessment: Current marketed and emerging therapies
Bacterial Vaginosis Market Dynamics: Bacterial Vaginosis Market drivers and Bacterial Vaginosis Market barriers
Competitive Intelligence Analysis: SWOT analysis, PESTLE analysis, Porter's five forces, BCG Matrix, Market entry strategies
Bacterial Vaginosis Market Unmet Needs: Insights into unmet needs, KOL's views, Analyst's views, Market Access, and Reimbursement.
To access the full report and gain a deeper understanding of Bacterial Vaginosis Market outlook, drug uptake, treatment scenario, and epidemiology trends: https://www.delveinsight.com/sample-request/bacterial-vaginosis-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=rkpr
Table of Content:
1 Key Insights
2 Report Introduction
3 Bacterial vaginosis Market Overview at a Glance
4 Bacterial vaginosis Epidemiology and Market Methodology
5 Executive Summary
6 Bacterial vaginosis Key Events
7 Bacterial vaginosis Disease Background and Overview
8 Bacterial vaginosis Epidemiology and Patient Population
9 Patient Journey
10 Bacterial vaginosis Marketed Therapies
11 Bacterial vaginosis Emerging Therapies
12 Bacterial vaginosis: Seven Major Market Analysis
13 Key Opinion Leaders' Views
14 Bacterial vaginosis Unmet Needs
15 Bacterial vaginosis SWOT Analysis
16 Bacterial vaginosis Drug Market Access and Reimbursement
17 Appendix
18 DelveInsight Capabilities
19 Disclaimer
20 About DelveInsight
Stay Ahead in a Competitive Landscape with Our Exhaustive Market Research Report-Dive Into Detailed Analysis, Key Trends, and Future Projections @ https://www.delveinsight.com/sample-request/bacterial-vaginosis-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=rkpr
List of Top Selling Market Research Reports in 2024
Surgical Energy Generators Market- https://www.delveinsight.com/report-store/surgical-energy-generators-market
Surgical Sealant Tissue Patch Market- https://www.delveinsight.com/report-store/surgical-sealant-tissue-patch-market
Surgical Stapling Devices Market- https://www.delveinsight.com/report-store/surgical-stapling-devices-market
Vital Sign Monitoring Devices Market- https://www.delveinsight.com/report-store/vital-sign-monitors-external-remote-patient-monitoring-devices-market
Syphilis Market- https://www.delveinsight.com/report-store/syphilis-market
Vitreoretinal Surgery Devices Market- https://www.delveinsight.com/report-store/vitreoretinal-surgery-devices-market
Pelvic Organ Prolapse Market- https://www.delveinsight.com/report-store/pelvic-organ-prolapse-market
Scoliosis Market- https://www.delveinsight.com/report-store/scoliosis-market
SGLT2 Inhibitors Market- https://www.delveinsight.com/report-store/sglt2-inhibitors-market
Urinary Catheters Market- https://www.delveinsight.com/report-store/urinary-catheters-market
Carcinoid Syndrome Market- https://www.delveinsight.com/report-store/carcinoid-syndrome-market
Cardiac Monitoring Devices Market- https://www.delveinsight.com/report-store/cardiac-monitoring-devices-market
Varicose Vein Treatment Devices Market- https://www.delveinsight.com/report-store/varicose-vein-treatment-devices-market
Bone Growth Stimulators Market- https://www.delveinsight.com/report-store/bone-growth-stimulators-market
Skin Neoplasms Market- https://www.delveinsight.com/report-store/skin-neoplasms-market
Thrombectomy Devices Market- https://www.delveinsight.com/report-store/thrombectomy-devices-market
Novel Drug Delivery Devices Market- https://www.delveinsight.com/report-store/novel-drug-delivery-devices
Lymphedema Market- https://www.delveinsight.com/report-store/lymphedema-market
Artificial Disc Market- https://www.delveinsight.com/report-store/artificial-disc-market
Exocrine Pancreatic Insufficiency Market- https://www.delveinsight.com/report-store/exocrine-pancreatic-insufficiency-epi-market
Fabry Disease Market- https://www.delveinsight.com/report-store/fabry-disease-market
Overactive Bladder Market- https://www.delveinsight.com/report-store/overactive-bladder-oab-market
Total Knee Arthroplasty Market- https://www.delveinsight.com/report-store/total-knee-arthroplasty-market
Hip Replacement Devices Market- https://www.delveinsight.com/report-store/hip-reconstruction-devices-market
Lactose Intolerance Market- https://www.delveinsight.com/report-store/lactose-intolerance-market
HDAC Inhibitors Market- https://www.delveinsight.com/report-store/hdac-inhibitors-market
Ventral Hernia Market- https://www.delveinsight.com/report-store/ventral-hernia-market
Facial Lines Market- https://www.delveinsight.com/report-store/facial-lines-market
Medical Marijuana Market- https://www.delveinsight.com/report-store/medical-marijuana-market-insight
Microscopy Device Market- https://www.delveinsight.com/report-store/microscopy-device-market
About DelveInsight
DelveInsight is a leading market research firm providing insightful solutions and services to pharmaceutical and life sciences companies. With a commitment to delivering accurate and comprehensive reports, DelveInsight empowers businesses to make informed decisions and navigate the complexities of the healthcare industry.
Company Name: DelveInsight Business Research LLP
Contact Person: Ram Kapoor
Email: info@delveinsight.com
Contact No.: +91-9650213330
City: 304 S. Jones Blvd #2432, Las Vegas
State: Nevada (89107)
Country: United States
Website: https://www.delveinsight.com/consulting
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Bacterial Vaginosis Market Insights, Epidemiology, and Market Forecast 2034 by Delveinsight here
News-ID: 3651546 • Views: …
More Releases from DelveInsight Business Research LLP

Genital Warts Pipeline Insights Report 2025 | DelveInsight
DelveInsight's, "Genital Warts Pipeline Insight 2025" report provides comprehensive insights about 30+ companies and 30+ pipeline drugs in Genital Warts pipeline landscape. It covers the Genital Warts pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
Explore the comprehensive insights by DelveInsight and stay ahead…

Traumatic Brain Injury Pipeline Drugs Report 2025 | DelveInsight
DelveInsight's "Traumatic Brain Injury Pipeline Insight 2025" report provides comprehensive insights about 20+ companies and 22+ pipeline drugs in Tthe raumatic Brain Injury pipeline landscape. It covers the Traumatic Brain Injury pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Traumatic Brain Injury pipeline therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
Explore…

Bone Metastasis Pipeline Assessment Report 2025 | DelveInsight
DelveInsight's, "Bone Metastases Pipeline Insight, 2025," report provides comprehensive insights about 10+ companies and 10+ pipeline drugs in Bone Metastases pipeline landscape. It covers the Bone Metastasis pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Bone Metastasis pipeline therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
Explore the comprehensive insights by DelveInsight…

Acquired Immunodeficiency Syndrome Treatment Market Size Report 2032 | DelveInsi …
DelveInsight's "Acquired Immunodeficiency Syndrome Market Insights, Epidemiology, and Market Forecast-2032′′ report offers an in-depth understanding of the Acquired Immunodeficiency Syndrome, historical and forecasted epidemiology as well as the Acquired Immunodeficiency Syndrome market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.
To Know in detail about the Acquired Immunodeficiency Syndrome market outlook, drug uptake, treatment scenario and epidemiology trends, Click here; Acquired Immunodeficiency Syndrome Market…
More Releases for Bacterial
Prominent Bacterial Conjunctivitis Market Trend for 2025: Innovative Eye Drops T …
What Are the Projected Growth and Market Size Trends for the Bacterial Conjunctivitis Market?
The bacterial conjunctivitis market has grown steadily, projected to expand from $4.52 billion in 2024 to $4.76 billion in 2025, at a CAGR of 5.3%. Growth factors include rising bacterial infection cases, improved diagnostics, patient education programs, stringent regulatory frameworks, and physician training.
The bacterial conjunctivitis market is projected to grow steadily, reaching $5.54 billion by 2029 at…
Community-Acquired Bacterial Pneumonia Market
DelveInsight's "Community-Acquired Bacterial Pneumonia Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the Community-Acquired Bacterial Pneumonia, historical and forecasted epidemiology as well as the Community-Acquired Bacterial Pneumonia market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.
The Community-Acquired Bacterial Pneumonia market report provides current treatment practices, emerging drugs, Community-Acquired Bacterial Pneumonia market share of the individual therapies, and current…
Bacterial Conjunctivitis Drugs Market Report 2018: Segmentation by Disease Type …
Global Bacterial Conjunctivitis Drugs market research report provides company profile for Pfizer Inc., Novartis AG, F. Hoffmann-La Roche, Bayer Healthcare, Valeant Pharmaceutical International Inc., Perrigo Company Plc, Akorn Inc., Santen Pharmaceutical Co. Ltd., Allergan Plc. and Others.
This market study includes data about consumer perspective, comprehensive analysis, statistics, market share, company performances (Stocks), historical analysis 2012 to 2017, market forecast 2018 to 2025 in terms of volume, revenue, YOY growth…
Bacterial Conjunctivitis Drugs Market: Rising Incidence of Ophthalmic Bacterial …
The U.S. market for bacterial conjunctivitis drugs has been declining sharply over the last few years. Analysts project the trend to continue in the coming years. In 2013, the market’s opportunity was valued at US$473.3 mn, which is likely to reduce to US$439.8 mn by 2024. In the coming years, the market will have to experience a patent cliff as the top U.S. brands of bacterial conjunctivitis drugs, such as…
Bacterial Conjunctivitis Drugs Market Driven by Rising Incidence of Ophthalmic B …
The U.S. market for bacterial conjunctivitis drugs is extremely fragmented, leading to commensurate competition among players. The entry barriers faced by new players despite having good research and development capabilities, is lack of capital, Transparency Market Research (TMR) states in its new report on the U.S. market for bacterial conjunctivitis drugs. R&D involves huge costs and this limits the production. Mergers and acquisitions and other forms of strategic alliances can…
Bacterial Conjunctivitis Drugs Market Driven by Rising Incidence of Ophthalmic B …
The U.S. market for bacterial conjunctivitis drugs has been declining sharply over the last few years. Analysts project the trend to continue in the coming years. In 2013, the market’s opportunity was valued at US$473.3 mn, which is likely to reduce to US$439.8 mn by 2024. In the coming years, the market will have to experience a patent cliff as the top U.S. brands of bacterial conjunctivitis drugs, such as…